BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37668982)

  • 1. Engineering SH2 Domains with Tailored Specificities and Affinities.
    Martyn GD; Veggiani G; Sidhu SS
    Methods Mol Biol; 2023; 2705():307-348. PubMed ID: 37668982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.
    Veggiani G; Huang H; Yates BP; Tong J; Kaneko T; Joshi R; Li SSC; Moran MF; Gish G; Sidhu SS
    Protein Sci; 2019 Feb; 28(2):403-413. PubMed ID: 30431205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revisiting the phosphotyrosine binding pocket of Fyn SH2 domain led to the identification of novel SH2 superbinders.
    Li S; Zou Y; Zhao D; Yin Y; Song J; He N; Liu H; Qian D; Li L; Huang H
    Protein Sci; 2021 Mar; 30(3):558-570. PubMed ID: 33314411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered SH2 Domains for Targeted Phosphoproteomics.
    Martyn GD; Veggiani G; Kusebauch U; Morrone SR; Yates BP; Singer AU; Tong J; Manczyk N; Gish G; Sun Z; Kurinov I; Sicheri F; Moran MF; Moritz RL; Sidhu SS
    ACS Chem Biol; 2022 Jun; 17(6):1472-1484. PubMed ID: 35613471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superbinder SH2 domains act as antagonists of cell signaling.
    Kaneko T; Huang H; Cao X; Li X; Li C; Voss C; Sidhu SS; Li SS
    Sci Signal; 2012 Sep; 5(243):ra68. PubMed ID: 23012655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a large family of superbinding bacterial SH2 domains.
    Kaneko T; Stogios PJ; Ruan X; Voss C; Evdokimova E; Skarina T; Chung A; Liu X; Li L; Savchenko A; Ensminger AW; Li SS
    Nat Commun; 2018 Oct; 9(1):4549. PubMed ID: 30382091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mode of ligand binding by the SH2 domain of the human XLP disease gene product SAP/SH2D1A.
    Li SC; Gish G; Yang D; Coffey AJ; Forman-Kay JD; Ernberg I; Kay LE; Pawson T
    Curr Biol; 1999 Dec; 9(23):1355-62. PubMed ID: 10607564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-O-(2-malonyl)tyrosine: a new phosphotyrosyl mimetic for the preparation of Src homology 2 domain inhibitory peptides.
    Ye B; Akamatsu M; Shoelson SE; Wolf G; Giorgetti-Peraldi S; Yan X; Roller PP; Burke TR
    J Med Chem; 1995 Oct; 38(21):4270-5. PubMed ID: 7473554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Creation of Phosphotyrosine Superbinders by Directed Evolution of an SH2 Domain.
    Huang H; Kaneko T; Sidhu SS; Li SS
    Methods Mol Biol; 2017; 1555():225-254. PubMed ID: 28092036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Introduction: History of SH2 Domains and Their Applications.
    Liu BA; Machida K
    Methods Mol Biol; 2017; 1555():3-35. PubMed ID: 28092024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loops govern SH2 domain specificity by controlling access to binding pockets.
    Kaneko T; Huang H; Zhao B; Li L; Liu H; Voss CK; Wu C; Schiller MR; Li SS
    Sci Signal; 2010 May; 3(120):ra34. PubMed ID: 20442417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptides as Baits for the Coprecipitation of SH2 Domain-Containing Proteins.
    Kiani A; Rios P; Köhn M
    Methods Mol Biol; 2023; 2705():359-369. PubMed ID: 37668984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of SH2 domains and phosphotyrosine signalling networks.
    Liu BA; Nash PD
    Philos Trans R Soc Lond B Biol Sci; 2012 Sep; 367(1602):2556-73. PubMed ID: 22889907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-phosphotyrosine proteome profiling by superbinder-SH2 domain affinity purification mass spectrometry, sSH2-AP-MS.
    Tong J; Cao B; Martyn GD; Krieger JR; Taylor P; Yates B; Sidhu SS; Li SS; Mao X; Moran MF
    Proteomics; 2017 Mar; 17(6):. PubMed ID: 27880036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface.
    Lubman OY; Waksman G
    J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual specificity of Src homology 2 domains for phosphotyrosine peptide ligands.
    Gay B; Furet P; García-Echeverría C; Rahuel J; Chène P; Fretz H; Schoepfer J; Caravatti G
    Biochemistry; 1997 May; 36(19):5712-8. PubMed ID: 9153411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM; Mitaxov V; Waksman G
    J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-Displayed SH2 Domain Libraries: From Ultrasensitive Tyrosine Phosphoproteome Probes to Translational Research.
    Martyn GD; Veggiani G
    Cold Spring Harb Protoc; 2024 May; 2024(5):107981. PubMed ID: 37197827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.